Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 48:2460–2469

Article  CAS  PubMed  Google Scholar 

Lila C, Delia R, Daniela D et al (2017) Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases [J]. Mediators Inflamm 2017:5048616

Google Scholar 

Uesugi N, Sakata N, Nagai R, Jono T, Horiuchi S, Takebayashi S (2000) Glycoxidative modification of AA amyloid deposits in renal tissue. Nephrol Dial Transplant 15:355–365

Article  CAS  PubMed  Google Scholar 

Bar KJ, Franke S, Wenda B, Muller S, Kientsch-Engel R, Stein G et al (2003) Pentosidine and n(epsilon)-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementia. Neurobiol Aging 24:333–338

Article  CAS  PubMed  Google Scholar 

Marchand F, Perretti M, McMahon SB (2005) Role of the immune system in chronic pain. Nat Rev Neurosci 6:521–532

Article  CAS  PubMed  Google Scholar 

Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14:591–604

Article  PubMed  PubMed Central  Google Scholar 

Shi S, Yin HJ, Li J, Wang L, Wang WP, Wang XL (2020) Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model. CNS Neurosci Ther 26:332–342

Article  CAS  PubMed  Google Scholar 

Su XQ, Wang XY, Gong FT, Feng M, Bai JJ, Zhang RR et al (2020) Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury. Brain Res Bull 158:1–8

Article  CAS  PubMed  Google Scholar 

Ward R, Li W, Abdul Y, Jackson L, Dong G, Jamil S et al (2019) NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia. Pharmacol Res 142:237–250

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai Y, Meng X, Ye T, Xie W, Sun G, Sun X (2018) Inhibiting the NLRP3 inflammasome activation with MCC950 ameliorates diabetic encephalopathy in db/db mice. Molecules 23:522

Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A et al (2013) NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493:674–678

Article  CAS  PubMed  Google Scholar 

Sarkar S, Malovic E, Harishchandra DS, Ghaisas S, Panicker N, Charli A et al (2017) Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease. NPJ Parkinsons Dis 3:30

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Liu L, Liu YZ, Shen XL, Wu TY, Zhang T et al (2015) NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol 18:pyv006

Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X (2016) NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun 56:175–186

Article  CAS  PubMed  Google Scholar 

Watanabe M, Toyomura T, Mori S (2022) Regulation of inflammatory response based on interaction among AGEs, DAMPs, and/or cytokines [J]. Nihon Yakurigaku Zasshi 157:429–433

Article  CAS  PubMed  Google Scholar 

Niwa T (2001) Dialysis-related amyloidosis: pathogenesis focusing on age modification. Semin Dial 14:123–126

Article  CAS  PubMed  Google Scholar 

Cho HJ, Xie C, Cai H (2018) Age-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression. Transl Neurodegener 7:1

Article  PubMed  PubMed Central  Google Scholar 

Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, Munch G (2003) Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs). J Neurochem 87:44–55

Article  CAS  PubMed  Google Scholar 

Lue LF, Kuo YM, Beach T, Walker DG (2010) Microglia activation and anti-inflammatory regulation in Alzheimer’s disease. Mol Neurobiol 41:115–128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheray M, Joseph B (2018) Epigenetics control microglia plasticity. Front Cell Neurosci 12:243

Article  PubMed  PubMed Central  Google Scholar 

Datta M, Staszewski O, Raschi E, Frosch M, Hagemeyer N, Tay TL et al (2018) Histone deacetylases 1 and 2 regulate microglia function during development, homeostasis, and neurodegeneration in a context-dependent manner. Immunity 48:514–529

Article  CAS  PubMed  Google Scholar 

Boche D, Perry VH, Nicoll JA (2013) Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3–18

Article  CAS  PubMed  Google Scholar 

Dai Y, Wang S, Chang S, Ren D, Shali S, Li C et al (2020) M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-kappaB/NLRP3 inflammasome signaling pathway. J Mol Cell Cardiol 142:65–79

Article  CAS  PubMed  Google Scholar 

Hu L, Zhang H, Wang B, Ao Q, He Z (2020) MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome activation. Int Immunopharmacol 80:106141

Article  CAS  PubMed  Google Scholar 

Devaraj S, Tobias P, Jialal I (2011) Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 55:441–445

Article  CAS  PubMed  Google Scholar 

Tang Y, Le W (2016) Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol 53:1181–1194

Article  CAS  PubMed  Google Scholar 

Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S et al (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752–758

Article  CAS  PubMed  Google Scholar 

Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318

Article  CAS  PubMed  Google Scholar 

Hayden MR (2019) Type 2 diabetes mellitus increases the risk of late-onset Alzheimer’s disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy. Brain Sci 9:262

Sadeghi A, Hami J, Razavi S, Esfandiary E, Hejazi Z (2016) The effect of diabetes mellitus on apoptosis in hippocampus: cellular and molecular aspects. Int J Prev Med 7:57

Article  PubMed  PubMed Central  Google Scholar 

Hwang IK, Choi JH, Nam SM, Park OK, Yoo DY, Kim W et al (2014) Activation of microglia and induction of pro-inflammatory cytokines in the hippocampus of type 2 diabetic rats. Neurol Res 36:824–832

Article  CAS  PubMed  Google Scholar 

Mastrocola R, Nigro D, Cento AS, Chiazza F, Collino M, Aragno M (2016) High-fructose intake as risk factor for neurodegeneration: key role for carboxy methyllysine accumulation in mice hippocampal neurons. Neurobiol Dis 89:65–75

Article  CAS  PubMed  Google Scholar 

Gao Y, Bielohuby M, Fleming T, Grabner GF, Foppen E, Bernhard W et al (2017) Dietary sugars, not lipids, drive hypothalamic inflammation. Mol Metab 6:897–908

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volny O, Kasickova L, Coufalova D, Cimflova P, Novak J (2015) MicroRNAs in cerebrovascular disease. Adv Exp Med Biol 888:155–195

Article  PubMed  Google Scholar 

Sadlon A, Takousis P, Alexopoulos P, Evangelou E, Prokopenko I, Perneczky R (2019) MiRNAs identify shared pathways in Alzheimer’s and Parkinson’s diseases. Trends Mol Med 25:662–672

Article  CAS  PubMed  Google Scholar 

Ma F, Zhang X, Yin KJ (2020) MicroRNAs in central nervous system diseases: a prospective role in regulating blood-brain barrier integrity. Exp Neurol 323:113094

Article  CAS  PubMed  Google Scholar 

Juzwik CA, Drake SS, Zhang Y, Paradis-Isler N, Sylvester A, Amar-Zifkin A et al (2019) MicroRNA dysregulation in neurodegenerative diseases: a systematic review. Prog Neurobiol 182:101664

Article  CAS  PubMed  Google Scholar 

Li L, Chen XP, Li YJ (2010) MicroRNA-146a and human disease. Scand J Immunol 71:227–231

Article  CAS  PubMed  Google Scholar 

Luo Q, Feng Y, Xie Y, Shao Y, Wu M, Deng X et al (2019) Nanoparticle-microRNA-146a-5p polyplexes ameliorate diabetic peripheral neuropathy by modulating inflammation and apoptosis. Nanomedicine 17:188–197

Article  CAS  PubMed